Hosted on MSN16h
Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock
Recursion Pharmaceuticals RXRX is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for ...
Medpage Today on MSN5d
Metastasis-Directed Therapy for Prostate Cancer a Clear Winner in Meta-Analysis
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy (MDT) in addition to systemic treatment, a meta-analysis of recent studies ...